Go offline with the Player FM app!
Measles, Pharma and Mistrust: A Conversation with MAHA Moms and Dr. Paul Offit
Manage episode 467596422 series 3645570
This week, in his first speech addressing the Department of Health and Human Services as its new chief, RFK Jr. said the path to the country earning back trust was through transparency.
As Kennedy was saying these words to a packed audience, Texas was clocking in more measles cases, in what is turning out to be its worst measles outbreak in 30 years. With rising mistrust in public health and declining vaccination rates, measles - a disease we eradicated over 20 years ago is making a comeback, worrying many in public health.
But two MAHA moms in their fifties we heard from on today's episode ask a question we are increasingly hearing more often these days: what's the big deal about measles? Both these moms got it as children and recovered, missed a few days of school and then had lifelong immunity. Is public health over reacting? They point to a classic Brady Bunch episode where the kids all catch measles, reflecting how the virus was once considered a rite of passage, a harmless childhood illness. If anything, doesn't getting a disease strengthen the immune system?
Before the vaccine, measles claimed the lives of 500 children every year and hospitalized tens of thousands more, and sometimes led to severe complications in kids many years after they got sick.
But now that we have a vaccine, what’s the real risk of measles today? And why is the measles vaccine -- while still popular among the vast majority of this country -- losing the trust of a small but growing group of Americans? In this episode, we welcome back Dr. Paul Offit, a leading expert on childhood vaccines, to explore the questions surrounding measles and dig into the facts about pharmaceutical funding while aiming to model a more constructive conversation.
Hosts:
Brinda Adhikari
Tom Johnson
Maggie Bartlett
Dr. Mark Abdelmalek
Guests:
Yesenia Muhammad, Atlanta, MAHA Mom
Melinda Hicks, Atlanta, MAHA Mom
Dr. Paul Offit, pediatrician, infectious disease and vaccine specialist
Sources:
States looking to create exemptions for public school vaccine mandates:
Public Attitudes on the MMR vaccine:
CDC numbers on risk from Measles
https://www.cdc.gov/measles/signs-symptoms/?CDC_AAref_Val=https://www.cdc.gov/measles/symptoms/complications.html#
Measles compromises immune memory
Measles virus infection diminishes preexisting antibodies that offer protection from other pathogens
Clinical Trial data on MMR:
Clinical evaluation of a new measles-mumps-rubella trivalent vac
Thanks for listening! If you like us, please leave a review, rate us, and please subscribe!
Got questions? Comments? We'd love to hear from you! Email us at [email protected]
Chapters
1. Measles, Pharma and Mistrust: A Conversation with MAHA Moms and Dr. Paul Offit (00:00:00)
2. Intro and headline (00:00:14)
3. Measles and the Brady Bunch (00:03:03)
4. The Measles Vaccine (00:06:11)
5. What Exactly Is Measles? (00:09:10)
6. Vaccination Rates are Dropping (00:17:24)
7. Outbreaks in Texas (00:18:36)
8. Conversation with Yesenia and Melinda, MAHA Moms (00:20:03)
9. "I Don't Think of Measles as Deadly. I Consider Ebola Deadly" (00:22:06)
10. "If Pharma Wants us to Take the Meds, Do Proper Studies" (00:23:28)
11. Welcome Dr. Paul Offit. Are We Making Too Big of a Deal of Measles? (00:26:05)
12. For Some, Measles Isn't the Threat. It's the Vaccine. (00:30:20)
13. Natural Immunity versus Getting a Vaccine. Which is Better? (00:33:07)
14. Doing Measles Vaccine Trials (00:35:10)
15. Who Pays for Clinical Trials? (00:37:15)
16. Can We Trust Pharma to Do These Trials Independently? (00:39:39)
17. Dr Offit on RFK Jr, Chronic Disease and Vaccines (00:47:00)
18. Why Should We Trust Dr. Offit? Why is he Doing This Work? (00:51:50)
19. Dr. Offit on Having Been Paid by Pharma (00:55:19)
20. Dr. Offit: I Am Not a Vaccine Advocate, I am a Science Advocate. (00:56:22)
21. Thank you. Please rate, review, like! (00:59:58)
26 episodes
Manage episode 467596422 series 3645570
This week, in his first speech addressing the Department of Health and Human Services as its new chief, RFK Jr. said the path to the country earning back trust was through transparency.
As Kennedy was saying these words to a packed audience, Texas was clocking in more measles cases, in what is turning out to be its worst measles outbreak in 30 years. With rising mistrust in public health and declining vaccination rates, measles - a disease we eradicated over 20 years ago is making a comeback, worrying many in public health.
But two MAHA moms in their fifties we heard from on today's episode ask a question we are increasingly hearing more often these days: what's the big deal about measles? Both these moms got it as children and recovered, missed a few days of school and then had lifelong immunity. Is public health over reacting? They point to a classic Brady Bunch episode where the kids all catch measles, reflecting how the virus was once considered a rite of passage, a harmless childhood illness. If anything, doesn't getting a disease strengthen the immune system?
Before the vaccine, measles claimed the lives of 500 children every year and hospitalized tens of thousands more, and sometimes led to severe complications in kids many years after they got sick.
But now that we have a vaccine, what’s the real risk of measles today? And why is the measles vaccine -- while still popular among the vast majority of this country -- losing the trust of a small but growing group of Americans? In this episode, we welcome back Dr. Paul Offit, a leading expert on childhood vaccines, to explore the questions surrounding measles and dig into the facts about pharmaceutical funding while aiming to model a more constructive conversation.
Hosts:
Brinda Adhikari
Tom Johnson
Maggie Bartlett
Dr. Mark Abdelmalek
Guests:
Yesenia Muhammad, Atlanta, MAHA Mom
Melinda Hicks, Atlanta, MAHA Mom
Dr. Paul Offit, pediatrician, infectious disease and vaccine specialist
Sources:
States looking to create exemptions for public school vaccine mandates:
Public Attitudes on the MMR vaccine:
CDC numbers on risk from Measles
https://www.cdc.gov/measles/signs-symptoms/?CDC_AAref_Val=https://www.cdc.gov/measles/symptoms/complications.html#
Measles compromises immune memory
Measles virus infection diminishes preexisting antibodies that offer protection from other pathogens
Clinical Trial data on MMR:
Clinical evaluation of a new measles-mumps-rubella trivalent vac
Thanks for listening! If you like us, please leave a review, rate us, and please subscribe!
Got questions? Comments? We'd love to hear from you! Email us at [email protected]
Chapters
1. Measles, Pharma and Mistrust: A Conversation with MAHA Moms and Dr. Paul Offit (00:00:00)
2. Intro and headline (00:00:14)
3. Measles and the Brady Bunch (00:03:03)
4. The Measles Vaccine (00:06:11)
5. What Exactly Is Measles? (00:09:10)
6. Vaccination Rates are Dropping (00:17:24)
7. Outbreaks in Texas (00:18:36)
8. Conversation with Yesenia and Melinda, MAHA Moms (00:20:03)
9. "I Don't Think of Measles as Deadly. I Consider Ebola Deadly" (00:22:06)
10. "If Pharma Wants us to Take the Meds, Do Proper Studies" (00:23:28)
11. Welcome Dr. Paul Offit. Are We Making Too Big of a Deal of Measles? (00:26:05)
12. For Some, Measles Isn't the Threat. It's the Vaccine. (00:30:20)
13. Natural Immunity versus Getting a Vaccine. Which is Better? (00:33:07)
14. Doing Measles Vaccine Trials (00:35:10)
15. Who Pays for Clinical Trials? (00:37:15)
16. Can We Trust Pharma to Do These Trials Independently? (00:39:39)
17. Dr Offit on RFK Jr, Chronic Disease and Vaccines (00:47:00)
18. Why Should We Trust Dr. Offit? Why is he Doing This Work? (00:51:50)
19. Dr. Offit on Having Been Paid by Pharma (00:55:19)
20. Dr. Offit: I Am Not a Vaccine Advocate, I am a Science Advocate. (00:56:22)
21. Thank you. Please rate, review, like! (00:59:58)
26 episodes
All episodes
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.